Thrombomodulin-mediated Inhibition of Neutrophil Extracellular Trap Formation Alleviates Hepatic Ischemia-reperfusion Injury by Blocking TLR4 in Rats Subjected to Liver Transplantation
- 16 September 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 106 (2), e126-e140
- https://doi.org/10.1097/tp.0000000000003954
Abstract
Background: Hepatic ischemia/reperfusion injury (IRI) is an unavoidable outcome of liver transplantation, during which neutrophil extracellular traps (NETs) may play a critical role in the IRI-induced immune response to inflammation. The purpose of this study was to identify the function of recombinant human thrombomodulin (rTM) in the remission of hepatic IRI after liver transplantation and elucidate the specific mechanism. Methods: NET formation was detected in the serum of liver transplantation patients and rats following liver transplantation. Hematoxylin-eosin (HE) staining, terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) staining, immunohistochemistry and immunofluorescence were used to assess the effect of rTM on NET formation in vitro and in vivo. Results: We found that rTM markedly inhibited neutrophil formation in NETs, reduced apoptosis in hepatocytes, alleviated rat hepatic IRI and improved liver function. In vitro, rTM inhibited neutrophil formation in NETs, and lipopolysaccharide (LPS) (a Toll-like receptor (TLR)-4 agonist) reversed the inhibitory effect of rTM on NET formation. rTM blocked TLR-4 and the downstream extracellular signal-regulated kinase (ERK)/c-Jun NH2 terminal kinase (JNK) and nicotinamide adenine dinucleotide phosphate (NADPH)/ROS/peptidylarginine deiminase 4 (PAD4) signaling pathways to protect against hepatic IRI and inhibit NET formation. In addition, we demonstrated that combined treatment with rTM and an NADPH oxidative inhibitor had a better effect than either treatment alone. Conclusions: NETs are a potential therapeutic target in hepatic IRI, and rTM could be used to prevent IR-induced hepatic injury. In addition, cotargeting NETosis-related signaling pathways might be a novel therapeutic strategy for hepatic IRI treatment.This publication has 39 references indexed in Scilit:
- Damage‐associated molecular pattern–activated neutrophil extracellular trap exacerbates sterile inflammatory liver injuryJournal of Hepatology, 2015
- Death upon a Kiss: Mitochondrial Outer Membrane Composition and Organelle Communication Govern Sensitivity to BAK/BAX-Dependent ApoptosisCell Chemical Biology, 2013
- Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosisCell Death & Differentiation, 2013
- Intravital Imaging of Neutrophil Recruitment in Hepatic Ischemia-Reperfusion Injury in MiceTransplantation, 2013
- Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysisIntensive Care Medicine, 2013
- Immunopathogenesis of ischemia/reperfusion-associated tissue damageClinical Immunology, 2011
- Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formationNature Chemical Biology, 2010
- Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis‐mediated cell deathFEBS Letters, 2010
- The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the ratJournal of Hepatology, 1996
- Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes.JCI Insight, 1985